<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Pathology</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/496B7214-5694-419C-AF23-78F025A48AF5"><gtr:id>496B7214-5694-419C-AF23-78F025A48AF5</gtr:id><gtr:firstName>John</gtr:firstName><gtr:surname>Trowsdale</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0901682"><gtr:id>B605D740-FEDC-410D-BD82-FE6AF0A93FFF</gtr:id><gtr:title>Human Natural Killer cell-related receptors: diversity, ligands and disease susceptibility.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0901682</gtr:grantReference><gtr:abstractText>Natural killer cells provide defence for your body against viruses and tumours. These cells have proteins on their surfaces, which allow them to detect cells that are infected or cancerous. This programme of research will examine these proteins in detail. We will find out how they differ between different people as this may help to understand why some people are susceptible to certain diseases. We also determine what the proteins are interacting with, in other words, their target molecules. This will help to understand how an infected or cancerous cell is recognised by the immune system.</gtr:abstractText><gtr:technicalSummary>Natural killer (NK) cells have a critical role in protection against viruses and tumours. They express a wide variety of both inhibitory and activating receptors, some of which are expressed on other immune cells. Some NK receptors, such as KIR and some LILR, are highly polymorphic, a feature that is probably driven by resistance to disease. This programme of research will focus on the diversity and functions of human NK receptor genes, adressing three specific aims: 1. We will identify and sequence novel KIR haplotypes and measure the frequency of formation of hybrid KIR genes. 2. We will identify ligands for some key activating receptors, as well as for KIR and adjacent related LILR loci, where these are unknown. We will probe ways in which their counter-receptor binding and functions are affected by polymorphic variation. Our working hypothesis is that is that KIR and LILR interact with MHC molecules complexed with endogenous self peptides, so that a variety of infections may be monitored by upregulation of a small set of proteins in infected cells 3. We will investigate the relationship between receptor variation and expression with disease, by developing a novel rapid KIR typing method.</gtr:technicalSummary><gtr:fund><gtr:end>2016-06-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2011-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1495128</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>School of Biological Sciences Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Biochemistry</gtr:department><gtr:description>OSCAR</gtr:description><gtr:id>3932BCB2-9B97-41E8-B442-BE66F2753D19</gtr:id><gtr:impact>Publication and patent</gtr:impact><gtr:partnerContribution>Richard Farndale has supplied numerous collagen peptides and has contributed intellectually</gtr:partnerContribution><gtr:piContribution>We have led the project on the functions of the OSCAR gene in the leucocyte receptor complex</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>314505</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC</gtr:description><gtr:end>2018-12-02</gtr:end><gtr:fundingOrg>MRC Headoffice</gtr:fundingOrg><gtr:fundingRef>MR/M020290/1</gtr:fundingRef><gtr:id>E4AE2BF8-BF48-4F8F-92C0-F2EC4047865D</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-12-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CE01C6D1-CA91-40B1-B808-5AC001F28264"><gtr:id>CE01C6D1-CA91-40B1-B808-5AC001F28264</gtr:id><gtr:title>Medawar and the immunological paradox of pregnancy: 60 years on.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/baa990e34423fce623db0afe90d21bf8"><gtr:id>baa990e34423fce623db0afe90d21bf8</gtr:id><gtr:otherNames>Colucci F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/680CDCA5-0193-4229-8D5B-81A22302A938"><gtr:id>680CDCA5-0193-4229-8D5B-81A22302A938</gtr:id><gtr:title>Copy number variation leads to considerable diversity for B but not A haplotypes of the human KIR genes encoding NK cell receptors.</gtr:title><gtr:parentPublicationTitle>Genome research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/96539f4c8df5c126548c576fee133c5d"><gtr:id>96539f4c8df5c126548c576fee133c5d</gtr:id><gtr:otherNames>Jiang W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1088-9051</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/607E5349-67CC-414A-8373-1DD5910D32AB"><gtr:id>607E5349-67CC-414A-8373-1DD5910D32AB</gtr:id><gtr:title>Regulation of Immunity by Butyrophilins.</gtr:title><gtr:parentPublicationTitle>Annual review of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/180a3baa4fd8918b9d49365fa2a8e310"><gtr:id>180a3baa4fd8918b9d49365fa2a8e310</gtr:id><gtr:otherNames>Rhodes DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0732-0582</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F9BA61DB-8826-4B2C-928F-83D41D427613"><gtr:id>F9BA61DB-8826-4B2C-928F-83D41D427613</gtr:id><gtr:title>Natural killer cells and their receptors in multiple sclerosis.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fb9c73b502f81abc35638f4e65342b3e"><gtr:id>fb9c73b502f81abc35638f4e65342b3e</gtr:id><gtr:otherNames>Kaur G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/660A419E-CC1E-4C83-AE18-0862CC4F7FCE"><gtr:id>660A419E-CC1E-4C83-AE18-0862CC4F7FCE</gtr:id><gtr:title>Tracing dynamic expansion of human NK-cell subsets by high-resolution analysis of KIR repertoires and cellular differentiation.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/48b4156117e36b36f5cca2eeb0d273a0"><gtr:id>48b4156117e36b36f5cca2eeb0d273a0</gtr:id><gtr:otherNames>B?ziat V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6393BE66-EA31-433D-916E-4721FB23160C"><gtr:id>6393BE66-EA31-433D-916E-4721FB23160C</gtr:id><gtr:title>Imputation of KIR Types from SNP Variation Data.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/30ec37511efbfaa35167d669ece3fc0b"><gtr:id>30ec37511efbfaa35167d669ece3fc0b</gtr:id><gtr:otherNames>Vukcevic D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AA7C3A81-34BA-4CF6-9AC4-8068F9390523"><gtr:id>AA7C3A81-34BA-4CF6-9AC4-8068F9390523</gtr:id><gtr:title>A KIR B centromeric region present in Africans but not Europeans protects pregnant women from pre-eclampsia.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4c3f977bd342d93e338864d30b631ab7"><gtr:id>4c3f977bd342d93e338864d30b631ab7</gtr:id><gtr:otherNames>Nakimuli A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B7B972CB-5DFF-4F61-9556-059A91FF799B"><gtr:id>B7B972CB-5DFF-4F61-9556-059A91FF799B</gtr:id><gtr:title>2DL1, 2DL2 and 2DL3 all contribute to KIR phenotype variability on human NK cells.</gtr:title><gtr:parentPublicationTitle>Genes and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fb9dabbec539a0989786388a49aa45ea"><gtr:id>fb9dabbec539a0989786388a49aa45ea</gtr:id><gtr:otherNames>Dunphy SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1466-4879</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E6F2CD05-F60A-4F21-A49E-7EA55ECE1552"><gtr:id>E6F2CD05-F60A-4F21-A49E-7EA55ECE1552</gtr:id><gtr:title>HLA class I allelic sequence and conformation regulate leukocyte Ig-like receptor binding.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/870746aad660e5cc5af23af0512f6e0c"><gtr:id>870746aad660e5cc5af23af0512f6e0c</gtr:id><gtr:otherNames>Jones DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5B1479CA-24C2-454F-9A7C-4158CAD2A769"><gtr:id>5B1479CA-24C2-454F-9A7C-4158CAD2A769</gtr:id><gtr:title>Impaired natural killer cell phenotype and function in idiopathic and heritable pulmonary arterial hypertension.</gtr:title><gtr:parentPublicationTitle>Circulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1b3bbe27015d9b0d2dedbe98dbf0e42a"><gtr:id>1b3bbe27015d9b0d2dedbe98dbf0e42a</gtr:id><gtr:otherNames>Ormiston ML</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0009-7322</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2AF97E19-6D7C-444A-A849-AB4355B4711B"><gtr:id>2AF97E19-6D7C-444A-A849-AB4355B4711B</gtr:id><gtr:title>Detection of weak receptor-ligand interactions using IgM and J-chain-based fusion proteins.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/76f83df1c6d261885c662ded384383de"><gtr:id>76f83df1c6d261885c662ded384383de</gtr:id><gtr:otherNames>Ammann JU</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A5F62A81-E844-4E9B-A9AD-94550E16350C"><gtr:id>A5F62A81-E844-4E9B-A9AD-94550E16350C</gtr:id><gtr:title>TAPBPR alters MHC class I peptide presentation by functioning as a peptide exchange catalyst.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5017bb8d1472035339a882f03147e36b"><gtr:id>5017bb8d1472035339a882f03147e36b</gtr:id><gtr:otherNames>Hermann C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D98E73AF-AB23-40FF-A0CF-C89E30588765"><gtr:id>D98E73AF-AB23-40FF-A0CF-C89E30588765</gtr:id><gtr:title>HLA variants related to primary sclerosing cholangitis influence rejection after liver transplantation.</gtr:title><gtr:parentPublicationTitle>World journal of gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c92fb57723813533d0b58302787c6c93"><gtr:id>c92fb57723813533d0b58302787c6c93</gtr:id><gtr:otherNames>Fosby B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1007-9327</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1C7257F8-9061-45A0-95D1-EB93443DF7AA"><gtr:id>1C7257F8-9061-45A0-95D1-EB93443DF7AA</gtr:id><gtr:title>Activation of human ?d T cells by cytosolic interactions of BTN3A1 with soluble phosphoantigens and the cytoskeletal adaptor periplakin.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/180a3baa4fd8918b9d49365fa2a8e310"><gtr:id>180a3baa4fd8918b9d49365fa2a8e310</gtr:id><gtr:otherNames>Rhodes DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B80D4CC7-67B3-40A8-8BFA-38747F1F1863"><gtr:id>B80D4CC7-67B3-40A8-8BFA-38747F1F1863</gtr:id><gtr:title>KIR haplotypes are associated with late-onset type 1 diabetes in European-American families.</gtr:title><gtr:parentPublicationTitle>Genes and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bdbd992e8d889853595e4e32d97cd79c"><gtr:id>bdbd992e8d889853595e4e32d97cd79c</gtr:id><gtr:otherNames>Traherne JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1466-4879</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/489918C7-D43F-4894-AFC3-76195B57211D"><gtr:id>489918C7-D43F-4894-AFC3-76195B57211D</gtr:id><gtr:title>Development and use of IgM/J-chain fusion proteins for characterization of immunoglobulin superfamily ligand-receptor interactions.</gtr:title><gtr:parentPublicationTitle>Current protocols in protein science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/76f83df1c6d261885c662ded384383de"><gtr:id>76f83df1c6d261885c662ded384383de</gtr:id><gtr:otherNames>Ammann JU</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1934-3655</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/232704F8-2CD4-4F10-9CBE-27370D09EBBB"><gtr:id>232704F8-2CD4-4F10-9CBE-27370D09EBBB</gtr:id><gtr:title>A novel family of human leukocyte antigen class II receptors may have its origin in archaic human species.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/41eb85be51db64e3522d04c4e00c7a3f"><gtr:id>41eb85be51db64e3522d04c4e00c7a3f</gtr:id><gtr:otherNames>Temme S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7995D2C0-B408-4767-B830-970FE1A2B5C9"><gtr:id>7995D2C0-B408-4767-B830-970FE1A2B5C9</gtr:id><gtr:title>Allele-specific recognition by LILRB3 and LILRA6 of a cytokeratin 8-associated ligand on necrotic glandular epithelial cells.</gtr:title><gtr:parentPublicationTitle>Oncotarget</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/870746aad660e5cc5af23af0512f6e0c"><gtr:id>870746aad660e5cc5af23af0512f6e0c</gtr:id><gtr:otherNames>Jones DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1949-2553</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/426ABFBB-74E9-41D0-AB18-80A672032CA9"><gtr:id>426ABFBB-74E9-41D0-AB18-80A672032CA9</gtr:id><gtr:title>Killer-cell Immunoglobulin-like Receptor gene linkage and copy number variation analysis by droplet digital PCR.</gtr:title><gtr:parentPublicationTitle>Genome medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/811ce9b3f3ffecde892e52b65ae3ff2b"><gtr:id>811ce9b3f3ffecde892e52b65ae3ff2b</gtr:id><gtr:otherNames>Roberts CH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1756-994X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5795ACAC-26D5-4DF8-B13D-3F948CB4B122"><gtr:id>5795ACAC-26D5-4DF8-B13D-3F948CB4B122</gtr:id><gtr:title>Characterisation of bovine leukocyte Ig-like receptors.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c192017b602ec7b14005eb6a5db63aa1"><gtr:id>c192017b602ec7b14005eb6a5db63aa1</gtr:id><gtr:otherNames>Hogan L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9A248AA2-3555-435E-9788-C093D8A83A2B"><gtr:id>9A248AA2-3555-435E-9788-C093D8A83A2B</gtr:id><gtr:title>A hybrid qPCR/SNP array approach allows cost efficient assessment of KIR gene copy numbers in large samples.</gtr:title><gtr:parentPublicationTitle>BMC genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ff367b188f493da912c48dd100b9b92e"><gtr:id>ff367b188f493da912c48dd100b9b92e</gtr:id><gtr:otherNames>Pontikos N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1471-2164</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0624895D-882C-40A0-B731-2E2251B76418"><gtr:id>0624895D-882C-40A0-B731-2E2251B76418</gtr:id><gtr:title>TARM1 Is a Novel Leukocyte Receptor Complex-Encoded ITAM Receptor That Costimulates Proinflammatory Cytokine Secretion by Macrophages and Neutrophils.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e3a06757b017d9fca6be564a0438f3b6"><gtr:id>e3a06757b017d9fca6be564a0438f3b6</gtr:id><gtr:otherNames>Radjabova V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/29B58CF2-FBC0-48D9-84D4-7ACE11850D2E"><gtr:id>29B58CF2-FBC0-48D9-84D4-7ACE11850D2E</gtr:id><gtr:title>OSCAR is a collagen receptor that costimulates osteoclastogenesis in DAP12-deficient humans and mice.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4e5ba539ca40e58fd10ec114f920a1da"><gtr:id>4e5ba539ca40e58fd10ec114f920a1da</gtr:id><gtr:otherNames>Barrow AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/66D15B31-A02E-4D6E-8892-728321303165"><gtr:id>66D15B31-A02E-4D6E-8892-728321303165</gtr:id><gtr:title>Copy number and nucleotide variation of the LILR family of myelomonocytic cell activating and inhibitory receptors.</gtr:title><gtr:parentPublicationTitle>Immunogenetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fec119ae527f26c89dad93748f0428d9"><gtr:id>fec119ae527f26c89dad93748f0428d9</gtr:id><gtr:otherNames>L?pez-?lvarez MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0093-7711</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0AA89BD6-E21B-43F6-8798-ED513C2C86AF"><gtr:id>0AA89BD6-E21B-43F6-8798-ED513C2C86AF</gtr:id><gtr:title>The interaction of genetic determinants in the outcome of HCV infection: evidence for discrete immunological pathways.</gtr:title><gtr:parentPublicationTitle>Tissue antigens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4436d4c018d7a185a5d862265e15d931"><gtr:id>4436d4c018d7a185a5d862265e15d931</gtr:id><gtr:otherNames>Hydes TJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0001-2815</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/491F9197-5238-4853-A842-B9D8A656CF85"><gtr:id>491F9197-5238-4853-A842-B9D8A656CF85</gtr:id><gtr:title>LILRB2 interaction with HLA class I correlates with control of HIV-1 infection.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/04b033b53a36ae1ac29e64b35fa545d0"><gtr:id>04b033b53a36ae1ac29e64b35fa545d0</gtr:id><gtr:otherNames>Bashirova AA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/163661A4-3BA3-4229-9C82-DA45F9B15C49"><gtr:id>163661A4-3BA3-4229-9C82-DA45F9B15C49</gtr:id><gtr:title>Killer immunoglobulin-like receptor gene repertoire influences viral load of primary human cytomegalovirus infection in renal transplant patients.</gtr:title><gtr:parentPublicationTitle>Genes and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/870746aad660e5cc5af23af0512f6e0c"><gtr:id>870746aad660e5cc5af23af0512f6e0c</gtr:id><gtr:otherNames>Jones DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1466-4879</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0901682</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>